Yang S, Liu A, Weidenhammer A, Cooksey RC, McClain D, Kim MK, Aguilera G, Abel ED, Chung JH
This 'failure to translate' is likely to be related primarily to our incomplete understanding of the pathogenic mechanisms underlying PD, and excessive reliance on data from toxin-based animal models to judge which agents should be selected for clinical trials
Daprodustat (Jesduvroq) was officially approved by the FDA on February 1, 2023, for the treatment of anemia due to chronic kidney disease
Mild gastrointestinal effects are among the most typical initial responses
By acting as a physical binder in the gut and simultaneously upregulating the synthesis of intracellular metal-binding proteins (metallothioneins), chlorella provides a comprehensive, scientifically validated defense against the environmental toxins that frequently exacerbate the symptoms of Long COVID and ME/CFS